Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Medical Genomics Research Department, |
RCV001003517 | SCV001160720 | uncertain significance | Maturity onset diabetes mellitus in young | 2019-11-01 | no assertion criteria provided | clinical testing | The Arg424His variant in EDEM2 located in a highly conserved amino acid region with arginine conserved up to Saccharomyces cerevisiae. Prediction software SIFT, PolyPhen-2, PROVEAN and PhD-SNP predicted the variant to be deleterious. Additionally, in vitro functional studies indicate that the EDEM2 disruption reduces the expression of beta-cell genes involved in the glucose-stimulated insulin secretion (GSIS) pathway leading to an overall suppression of insulin secretion. |